Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Serum Heavy/Light Chain and Free Light Chain Measurements Provide Prognostic Information, Allow Creation of a Prognostic Model and Identify Clonal Changes (clonal tiding) Through the Course of Multiple Myeloma (MM)

Heinz Ludwig, MD, Jeffrey Faint, Niklas Zojer, Arthur R Bradwell, Philip Young, Dejan Milosavljevic, Wolfgang Hübl, Stephen Harding

Blood (2011) 118 (21): 2883.

https://doi.org/10.1182/blood.V118.21.2883.2883

Published: 2011

Journal Articles

Acquired Hemophilia Associated with Smoldering Myeloma: Demonstration That the Monoclonal Gammopathy Acts as the Factor VIII Inhibitor.

Olivier Decaux, Benoit Guillet, Arnaud Millet, Stephen Harding, Arthur R. Bradwell, Bernard Grosbois, Patrick Jego

Blood (2009) 114 (22): 1307.

https://doi.org/10.1182/blood.V114.22.1307.1307

Published: 2009

Journal Articles

Abnormal Serum Free Light Chain Ratios Are Associated with Earlier Time to First Treatment and Poor Survival in Patients with Chronic Lymphocytic Leukaemia

Guy Pratt, Graham Mead, PhD, Supratik Basu, MBBS, MD, Abe Jacobs, Roger Holder, Chris Fegan, Chris Pepper, Arthur R. Bradwell, David Oscier, Stephen Harding

Blood (2008) 112 (11): 3141.

https://doi.org/10.1182/blood.V112.11.3141.3141

Published: 2008

Journal Articles

Immunoassays for IgG and IgA Light Chain Pairs Are More Sensitive Than Immunofixation Electrophoresis in Multiple Myeloma and Provide Quantitative Analysis

Arthur R. Bradwell, Graham Mead, PhD, Mark T Drayson, Stephen Harding

Blood (2008) 112 (11): 5109.

https://doi.org/10.1182/blood.V112.11.5109.5109

Published: 2008

Journal Articles

Appraisal of immunoglobulin free light chain as a marker of response

Angela Dispenzieri, Lijun Zhang, Jerry A. Katzmann, Melissa Snyder, Emily Blood, Roberta DeGoey, Kimberly Henderson, Robert A. Kyle, Martin M. Oken, Arthur R. Bradwell, Philip R. Greipp

Blood (2008) 111 (10): 4908–4915.

https://doi.org/10.1182/blood-2008-02-138602

Published: 2008

Journal Articles

Renal Recovery Following Light Chain Removal by Extended Haemodialysis in a Patient with Cast Nephropathy.

Colin A. Hutchison, MBChB, Mark Cook, MBChB,PhD, Arthur R. Bradwell, MBChB, FRCP,FRCPath, Paul Cockwell, MBChB,PhD

Blood (2006) 108 (11): 5115.

https://doi.org/10.1182/blood.V108.11.5115.5115

Published: 2006

Journal Articles

Monoclonal Gammopathy as a Determinant of Adverse Outcomes in Patients with Chronic Kidney Disease.

Colin A. Hutchison, MBChB, John Townend, MBChB, MD, Graham P. Mead, PhD, Katie Chandler, BSc, Jo Harper, BSc, Arthur R. Bradwell, MBChB, FRCP, FRCPath, Rosetta Zakeri, MBChB, Paul Cockwell, MBChB, PhD

Blood (2006) 108 (11): 5053.

https://doi.org/10.1182/blood.V108.11.5053.5053

Published: 2006

Journal Articles

Efficient Removal of Immunoglobulin Free Light Chains by Hemodialysis in Multiple Myeloma: In-Vitro and In-Vivo Studies.

Colin A. Hutchison, MBChB, Paul Cockwell, MBChB, PhD, Steven Reid, BSc, PhD, Katie Chandler, BSc, Graham P. Mead, BSc, PhD, John Harrison, John Hattersley, BSc, Neil D. Evans, BSc, MSc, PhD, Michael J. Chappell, BSc, MSc, PhD, Mark Cook, FRCP, Hermann Goehl, PhD, Markus Storr, PhD, Arthur R. Bradwell, MBChB, FRCP

Blood (2006) 108 (11): 5112.

https://doi.org/10.1182/blood.V108.11.5112.5112

Published: 2006

Journal Articles

Circulating amyloidogenic free light chains and serum N-terminal natriuretic peptide type B decrease simultaneously in association with improvement of survival in AL

Giovanni Palladini, Francesca Lavatelli, Paola Russo, Stefano Perlini, Vittorio Perfetti, Tiziana Bosoni, Laura Obici, Arthur R. Bradwell, GianVico Melzi D'Eril, Roberto Fogari, Remigio Moratti, Giampaolo Merlini

Blood (2006) 107 (10): 3854–3858.

https://doi.org/10.1182/blood-2005-11-4385

Published: 2006

Journal Articles

Rapid Removal of Free Light Chains from Serum by Hemodialysis for Patients with Myeloma Kidney.

Arthur R. Bradwell, MB, ChB, FRCP, Neil D. Evans, PhD, Mike J. Chappell, PhD, Paul Cockwell, FRCP, Steven D. Reid, PhD, John Harrison, Colin Hutchison, MRCP, Graham P. Mead, PhD

Blood (2005) 106 (11): 3482.

https://doi.org/10.1182/blood.V106.11.3482.3482

Published: 2005

Journal Articles

Standard Oral Melphalan Chemotherapy for AL Amyloidosis Revisited Using the Serum Free Light Chain Assay.

Mark Offer, Ashutosh D. Wechalekar, Hugh J.B. Goodman, Julian D. Gillmore, Helen J. Lachmann, Arthur R. Bradwell, Philip N. Hawkins

Blood (2005) 106 (11): 3495.

https://doi.org/10.1182/blood.V106.11.3495.3495

Published: 2005

Journal Articles

Efficacy of Risk Adapted Cyclophosphamide, Thalidomide and Dexamethasone in Systemic AL Amyloidosis.

Ashutosh D. Wechalekar, Hugh J.B. Goodman, Julian D. Gillmore, Helen J. Lachmann, Mark Offer, Arthur R. Bradwell, Philip N. Hawkins

Blood (2005) 106 (11): 3496.

https://doi.org/10.1182/blood.V106.11.3496.3496

Published: 2005

Journal Articles

Clinical Profile and Treatment Outcome in 92 Patients with AL Amyloidosis Associated with IgM Paraproteinaemia.

Ashutosh D. Wechalekar, Hugh J.B. Goodman, Julian D. Gillmore, Helen J. Lachmann, Mark Offer, Arthur R. Bradwell, Philip N. Hawkins

Blood (2005) 106 (11): 3498.

https://doi.org/10.1182/blood.V106.11.3498.3498

Published: 2005

Journal Articles

Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance

S. Vincent Rajkumar, Robert A. Kyle, Terry M. Therneau, L. Joseph Melton, III, Arthur R. Bradwell, Raynell J. Clark, Dirk R. Larson, Matthew F. Plevak, Angela Dispenzieri, Jerry A. Katzmann

Blood (2005) 106 (3): 812–817.

https://doi.org/10.1182/blood-2005-03-1038

Published: 2005

Journal Articles

Intermediate Dose Intravenous Melphalan and Dexamethasone Treatment in 144 Patients with Systemic AL Amyloidosis.

Hugh J.B. Goodman, FRACP FRCPA, Helen J. Lachmann, MD MRCP, Arthur R. Bradwell, FRCP FRCPath, Philip N. Hawkins, PhD FRCP

Blood (2004) 104 (11): 755.

https://doi.org/10.1182/blood.V104.11.755.755

Published: 2004

Journal Articles

Presence of an Abnormal Serum Free Light Ratio Is an Independent Risk Factor for Progression in Monoclonal Gammopathy of Undetermined Significance (MGUS).

S. Vincent Rajkumar, MD, Robert A. Kyle, MD, Terry M. Therneau, PhD, L. Joseph Melton, III, MD, Arthur R. Bradwell, MB ChB, Raynell J. Clark, Dirk R. Larson, Matthew F. Plevak, Jerry A. Katzmann, PhD

Blood (2004) 104 (11): 3647.

https://doi.org/10.1182/blood.V104.11.3647.3647

Published: 2004

Journal Articles

Serum Free Kappa to Free Lambda Ratios as an Adjunct to Serum Protein Electrophoresis for the Detection of Monoclonal Proteins in the Serum.

Arthur R. Bradwell, MB ChB, Jean Garbincius, B.A., Earle W. Holmes, Ph.D.

Blood (2004) 104 (11): 4856.

https://doi.org/10.1182/blood.V104.11.4856.4856

Published: 2004

Journal Articles

Correlation of Serum Free Light Chains and Bone Marrow Plasma Cell Infiltration in Multiple Myeloma.

Graham P. Mead, PhD, Steven D. Reid, PhD, Bradley M. Augustson, MB;BS, Mark T. Drayson, MB;BS, Arthur R. Bradwell, MD, J. Anthony Child, MD

Blood (2004) 104 (11): 4865.

https://doi.org/10.1182/blood.V104.11.4865.4865

Published: 2004

Journal Articles

Serum Free Light Chain Levels in Asymptomatic Myeloma.

Bradley M. Augustson, MB;BS, Steven D. Reid, PhD, Graham P. Mead, PhD, Mark T. Drayson, PhD, J. Anthony Child, MD, Arthur R. Bradwell, MD

Blood (2004) 104 (11): 4880.

https://doi.org/10.1182/blood.V104.11.4880.4880

Published: 2004

Journal Articles

Influence of plasma immunoglobulin level on antibody synthesis

Andreas Goldammer, Kurt Derfler, Kurt Herkner, Arthur R. Bradwell, Walter H. Hörl, Martin Haas

Blood (2002) 100 (1): 353–355.

https://doi.org/10.1182/blood-2002-01-0128

Published: 2002

NARROW

Serum Heavy/Light Chain and Free Light Chain Measurements Provide Prognostic Information, Allow Creation of a Prognostic Model and Identify Clonal Changes (clonal tiding) Through the Course of Multiple Myeloma (MM)

Acquired Hemophilia Associated with Smoldering Myeloma: Demonstration That the Monoclonal Gammopathy Acts as the Factor VIII Inhibitor.

Abnormal Serum Free Light Chain Ratios Are Associated with Earlier Time to First Treatment and Poor Survival in Patients with Chronic Lymphocytic Leukaemia

Immunoassays for IgG and IgA Light Chain Pairs Are More Sensitive Than Immunofixation Electrophoresis in Multiple Myeloma and Provide Quantitative Analysis

Appraisal of immunoglobulin free light chain as a marker of response

Renal Recovery Following Light Chain Removal by Extended Haemodialysis in a Patient with Cast Nephropathy.

Monoclonal Gammopathy as a Determinant of Adverse Outcomes in Patients with Chronic Kidney Disease.

Efficient Removal of Immunoglobulin Free Light Chains by Hemodialysis in Multiple Myeloma: In-Vitro and In-Vivo Studies.

Circulating amyloidogenic free light chains and serum N-terminal natriuretic peptide type B decrease simultaneously in association with improvement of survival in AL

Rapid Removal of Free Light Chains from Serum by Hemodialysis for Patients with Myeloma Kidney.

Standard Oral Melphalan Chemotherapy for AL Amyloidosis Revisited Using the Serum Free Light Chain Assay.

Efficacy of Risk Adapted Cyclophosphamide, Thalidomide and Dexamethasone in Systemic AL Amyloidosis.

Clinical Profile and Treatment Outcome in 92 Patients with AL Amyloidosis Associated with IgM Paraproteinaemia.

Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance

Intermediate Dose Intravenous Melphalan and Dexamethasone Treatment in 144 Patients with Systemic AL Amyloidosis.

Presence of an Abnormal Serum Free Light Ratio Is an Independent Risk Factor for Progression in Monoclonal Gammopathy of Undetermined Significance (MGUS).

Serum Free Kappa to Free Lambda Ratios as an Adjunct to Serum Protein Electrophoresis for the Detection of Monoclonal Proteins in the Serum.

Correlation of Serum Free Light Chains and Bone Marrow Plasma Cell Infiltration in Multiple Myeloma.

Serum Free Light Chain Levels in Asymptomatic Myeloma.

Influence of plasma immunoglobulin level on antibody synthesis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only